Moderna Joins Top Firms in S&P 500 After Value Nearly Triples
(Bloomberg) — Moderna Inc. joins the S&P 500 on Wednesday as the index’s the best performing stock this year — by a mile.The…
Stock Analysis
Nasdaq beats profit estimates on trading strength
Continued volatility in stock markets, fueled in part by a cohort of retail investors using mobile apps like Robinhood, drove…
Nasdaq beats profit estimates on trading strength – Reuters
Exchange operator Nasdaq Inc (NDAQ.O) reported a better-than-expected quarterly profit on Wednesday, boosted by strength in its…
The Downsides of Retirement That Nobody Talks About
If you haven’t properly prepared for leaving the working world and living without a paycheck, you’ll have to face the ugly truths…
Paytm and Zomato IPOs Point to Coming Wave of Indian Tech Listings – The Wall Street Journal
Paytm and Zomato IPOs Point to Coming Wave of Indian Tech Listings  The Wall Street Journal
Volatile interest rates cause mortgage demand to drop
A mixed picture of mortgage rates last week was enough to put the brakes on a recent rise in refinance demand.
Berkshire Hills Reports Higher Second Quarter Earnings
BOSTON, July 21, 2021 /PRNewswire/ — Berkshire Hills Bancorp, Inc. (NYSE: BHLB) today announced that second quarter 2021 delivered…
M&T Bank Corporation Announces Second Quarter Results
BUFFALO, N.Y., July 21, 2021 /PRNewswire/ — M&T Bank Corporation (“M&T”) (NYSE: MTB) today reported its results of operations…
Ascentage Pharma’s MDM2-p53 Inhibitor APG-115 (Alrizomadlin) Granted an Orphan Drug Designation by the FDA for the Treatment of Stage IIB-IV Melanoma, Marking the Twelfth Obtained by the Company
SUZHOU, China and ROCKVILLE, Md., July 21, 2021 /PRNewswire/ — Ascentage Pharma (6855.HK), a globally focused biotechnology…
Need to Know: This technical support shows the strength of the buy-the-dip force in markets
The firepower driving this market harder is a tough one to bet against.